Malignant Brain Tumors Completed Phase 1 Trials for Erlotinib (DB00530)

Also known as: Malignant Brain Tumor

IndicationStatusPhase
DBCOND0050591 (Malignant Brain Tumors)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00418327Safety Study of Tarceva in Children With Refractory and Relapsed Malignant Brain Tumors and Newly Diagnosed Brain Stem GliomaTreatment